Shareholding disclosure

CI Investments Inc

Declared position

Threshold

Fell below threshold

Timeline

Published

24.12.2024

Transaction

17.12.2024

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

ZA03-000000000PHE6

Beneficial owner

CI Investments Inc

Declared address

CI Investments Inc., Toronto, CA

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

CI Investments Inc

Basilea Pharmaceutica AG, Allschwil24.12.2024ZA03-000000000PHE6

Disclosure summary

CI Investments Inc disclosed a holding in Basilea Pharmaceutica AG, Allschwil that fell below the publication threshold, published by SIX Exchange Regulation on 24.12.2024, at 3% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

CI Investments Inc disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 24.12.2024.

Publication date24.12.2024

Transaction date17.12.2024

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerCI Investments Inc

Declared addressCI Investments Inc., Toronto, CA

CategoryCollective investment vehicle

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDZA03-000000000PHE6

Source: SIX Exchange Regulation · Publication date: 24.12.2024

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open